GeoVax vaccine targeting virus in two places shows promise; virus may become resistant to antibody drugs, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

An experimental vaccine developed by GeoVax Labs Inc succeeded in promoting development of antibodies that target two different sites on the virus in a small pilot study and has been advanced to mid-stage clinical trials, researchers reported., An experimental vaccine developed by GeoVax Labs Inc succeeded in promoting development of antibodies that target two different sites on the virus in a small pilot study and has been advanced to mid-stage clinical trials, researchers reported., , Read More